Ads
related to: gis network analysis
Search results
People using popular drugs for weight loss, diabetes are more likely to be diagnosed with stomach...
CNN.com· 1 day agoInjected medications that treat diabetes and obesity increase the risk of a rare but serious side...
Stomach paralysis risk may rise in people taking Ozempic and similar drugs
Medical Xpress· 24 hours ago"Although these drugs do work and should be used for the right reason, we just want to caution...
Karmanos Welcomes Wasif Saif, M.D., to Lead Phase 1 Clinical Trials
FOX 59 Indianapolis· 1 day agoInternationally known clinical and translational researcher also co-leads the GI oncology team DETROIT, May 20, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute ...
Crohn's disease, gut health, and mental health: What's the link?
Medical News Today· 7 days agoStress can contribute to anxiety and depression when living with a condition such as Crohn’s...
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid...
Digital Journal· 1 day agoBuloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment. The data were orally presented at the ATS International Congress and will be reviewed ...
SKT unveils AI-enabled fixed network controller
TelecomTV· 4 days agoSK Telecom has deployed an AI-enabled fixed network management platform, dubbed AI Orchestrator, that will “significantly improve network operations...
Statistics Canada Counts on Tech to Bolster Census Operations
The Wall Street Journal· 6 days agoIn such instances, if an address cannot be entered to generate a secure access code, respondents may...
Rekor And MS2 Join Forces To Accelerate State DOT Transition To Digital Infrastructure And AI-Based...
Morningstar· 1 day agoCOLUMBIA, MD / ACCESSWIRE / May 20, 2024 / Rekor Systems, Inc. (NASDAQ:REKR) ("Rekor" or the "Company"), a leader in developing and implementing state-of-the-art roadway intelligence technology ...
Prometheus Laboratories Presents Data Demonstrating Clinical Validity, Utility, and Positive...
Digital Journal· 1 day agoThe meeting showcases more than 5,600 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org ...
Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive...
CBS 47 Fresno· 4 days agoCelltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients with moderately to severely active Crohn's ...
